A safety and efficacy study of Velphoro for treating hyperphosphataemia in adults in China .

Trial Profile

A safety and efficacy study of Velphoro for treating hyperphosphataemia in adults in China .

Planning
Phase of Trial: Phase I/II

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs Sucroferric oxyhydroxide (Primary)
  • Indications Hyperphosphataemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Mar 2018 New trial record
    • 15 Mar 2018 According to a Vifor Pharma media release, company expected to conduct this study in 2018 in china.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top